Exploiting Dependence of Castration-Resistant Prostate Cancer on the Arginine Vasopressin Signaling Axis by Repurposing Vaptans.
Laine M HeidmanNahuel PeinettiValeria A CopelloKerry L BurnsteinPublished in: Molecular cancer research : MCR (2022)
The arginine vasopressin signaling axis in CRPC provides a therapeutic window that is targetable through repurposing safe and effective AVPR1A and AVPR2 antagonists.
Keyphrases